Percutaneous coronary intervention (PCI) is a standard treatment for significant coronary artery disease. Cardiologists use a catheter to place a stent that opens up the blockage and restores blood ...

In an examination of the appropriateness of the widespread use of percutaneous coronary interventions (PCIs), researchers found that of more than 500,000 PCIs included in the study, nearly all for ...

Global Percutaneous Coronary Intervention (PCI) Devices Market to Reach $19. 1 Billion by 2027. Amid the COVID-19 crisis, the global market for Percutaneous Coronary Intervention (PCI) Devices ...

Five-year follow-up data from the RENOVATE-COMPLEX-PCI trial show that intravascular imaging–guided percutaneous coronary ...

PCI reduces angina frequency in stable coronary artery disease regardless of age, with older patients deriving the greatest symptomatic benefit.

A recent retrospective study found that performing Chronic Total Occlusion Percutaneous Coronary Intervention (CTO-PCI) within 45 days of an Acute Coronary Syndrome (ACS) event does not improve ...

Certification to perform catheter-based interventions for coronary artery disease was originally limited to hospitals that had the capability to perform cardiac surgery on site. However, there has ...

Stenting guided by intravascular imaging rather than angiography is linked to a lower risk for target vessel failure in ...

Three presentations at ACC reinforce Heartflow’s AI-powered technology predicts MACE, drives superior lipid outcomes and results in ...

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today its CorPath® ...